Patents by Inventor Vikram Krishna Ramanathan

Vikram Krishna Ramanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N'-(2-CHLORO-6-METHYLBENZOYL)-4-METHYL-3-[2-(3-QUINOLYL)ETHYNYL]-BENZOHYDRAZIDE FOR TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20230301982
    Abstract: The present invention provides a method for preventing or treating Alzheimer’s disease and symptoms thereof comprising administering to a subject in need thereof a therapeutically effective amount of N?-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide or a its pharmaceutically acceptable salts, wherein the prevention and/or treatment of said disease and symptoms thereof is achieved by inhibition of amyloid-beta (A?) plaque aggregation, tau hyperphosphorylation, c-Abl kinase or a combination thereof. Also disclosed is the use of a therapeutically effective amount of N?-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide or its pharmaceutically acceptable salts to inhibit amyloid-beta (A?) plaque aggregation, tau hyperphosphorylation, c-Abl kinase or a combination thereof.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 28, 2023
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
    Inventors: Nitin Krishnaji DAMLE, Sanjay Nandlalji MANDHANE, Durgesh Ashok Kumar SONI, Shakti Kamalchand JAIN, Vikram Krishna RAMANATHAN
  • Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors
    Publication number: 20110190369
    Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.
    Type: Application
    Filed: April 11, 2011
    Publication date: August 4, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Mohammad SALMAN, Jitendra SATTIGERI, Yatendra KUMAR, Ram Chander ARYAN, Vikram Krishna RAMANATHAN, Anita CHUGH
  • Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors
    Publication number: 20110190296
    Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.
    Type: Application
    Filed: April 11, 2011
    Publication date: August 4, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Mohammad SALMAN, Jitendra SATTIGERI, Yatendra KUMAR, Ram Chander ARYAN, Vikram Krishna RAMANATHAN, Anita CHUGH
  • Substituted pyrrole derivatives and their use as HMG-CO inhibitors
    Patent number: 7923467
    Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: April 12, 2011
    Assignee: Ranbaxy Laboratories, Inc.
    Inventors: Mohammad Salman, Jitendra Sattigeri, Yatendra Kumar, Ram Chander Aryan, Vikram Krishna Ramanathan, Anita Chugh
  • Substituted Pyrrole Derivatives And Their Use As HMG-CO Inhibitors
    Publication number: 20100056602
    Abstract: The present invention relates to substituted pyrrole derivatives, which can be used as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. Compounds disclosed herein can function as cholesterol lowering agents and can be used for the treatment of cholesterol-related diseases and related symptoms. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and methods of treating cholesterol-related diseases and related symptoms.
    Type: Application
    Filed: May 28, 2004
    Publication date: March 4, 2010
    Inventors: Mohammad Salman, Jitendra Sattigeri, Yatendra Kumar, Ram Chander Aryan, Vikram Krishna Ramanathan, Anita Chugh